MR编号 | FR/V/0306/001 |
---|
药品名称 | EURICAN DAPPI |
---|
活性成分 | - canine adenovirus 0.0 CCID50
- canine distemper virus 0.0 CCID50
- canine parainfluenza virus 0.0 CCID50
- canine parvovirus 0.0 CCID50
|
---|
剂型 | Lyophilisate and solvent for suspension for injection |
---|
上市许可持有人 | MERIAL |
---|
参考成员国 - 产品名称 | France (FR) EURICAN DAPPI |
---|
互认成员国 - 产品名称 | - Germany (DE)
Eurican DAPPi - Denmark (DK)
Eurican DAPPi - Belgium (BE)
Eurican DAPPi - Netherlands (NL)
- Luxembourg (LU)
- United Kingdom (Northern Ireland) (XI)
EURICAN CHPPi2 - Ireland (IE)
- Austria (AT)
Eurican DAPPi Lyophilisat und Lösungsmittel zur Herstellung einer Injektionssuspension - Spain (ES)
- Portugal (PT)
- Italy (IT)
- Greece (GR)
- Sweden (SE)
- Norway (NO)
- Finland (FI)
- Poland (PL)
- Latvia (LV)
Eurican DAPPi - Lithuania (LT)
- Estonia (EE)
- Hungary (HU)
Eurican DHPPi2 vakcina A.U.V. - Bulgaria (BG)
- Cyprus (CY)
- Czechia (CZ)
EURICAN DAPPi lyofilizát a rozpouštědlo pro injekční suspenzi - Romania (RO)
- Slovakia (SK)
- Slovenia (SI)
- Malta (MT)
- Croatia (HR)
|
---|
许可日期 | 2016/02/24 |
---|
最近更新日期 | 2024/07/04 |
---|
药物ATC编码 | - QI07AD04 canine distemper virus + canine adenovirus + canine parvovirus + canine parainfluenza virus
|
---|
申请类型 | - TypeLevel1:[not specified]
- TypeLevel2:[not specified]
- TypeLevel3:Full dossier - art 12.3 Dir 2001/82/EC
- TypeLevel4:[not specified]
- TypeLevel5:[not specified]
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|